Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07266129 | Virtual Biopsy of Prostate Cancer Using PSMA PET and AI | recruiting | — | 220 | University Hospital of North NorwayOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT05526989 | Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma | recruiting | Phase 2 | 25 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT07180381 | Sequential Imaging of Suspicion of Prostate Cancer Reducing Overdiagnosis and Unnecessary Biopsy With Timely Diagnosis of Significant Cancer(SPROUT) | recruiting | N/A | 503 | St. Antonius HospitalOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT05893381 | Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)(LUST) | recruiting | Phase 2 | 70 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT07260435 | Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer(Apa/Enza-short) | recruiting | Phase 3 | 400 | Nick BeijeOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT05786716 | DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations(DETERMINE) | recruiting | Phase 2 / Phase 3 | 30 | Cancer Research UKOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT07258056 | GUidance In Prostate Cancer DEtection With 18F-PSMA-1007-PET/MRI and Targeted Biopsies(GUIDE PSMA PET) | recruiting | N/A | 100 | Mads Ryo JochumsenOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT06200558 | ARON-3 Study: International Multicentric Retrospective Study to Collect Global Experiences in the Treatment of Patients With Metastatic PCa | recruiting | — | 534 | Hospital of MacerataOTHER | 1 | Nov 26, 2025 | clinicaltrials |
| NCT07250542 | A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer | recruiting | Phase 2 | 30 | baotai LiangOTHER | 1 | Nov 26, 2025 | clinicaltrials |
| NCT01961713 | Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy | recruiting | — | 200 | Massachusetts General HospitalOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT07249281 | MR Microstructural Imaging for Prostate Cancer Diagnosis | recruiting | — | 2,000 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT05384535 | Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort | recruiting | N/A | 100 | Northwell HealthOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05739565 | Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer Patients(ACTI-PAIR2) | recruiting | N/A | 850 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05965180 | Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe | recruiting | — | 50 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT06126731 | Combination Study of Antibiotics With Enzalutamide (PROMIZE) | recruiting | Phase 1 / Phase 2 | 39 | Institute of Cancer Research, United KingdomOTHER | 2 | Nov 24, 2025 | clinicaltrials |
| NCT07106827 | A Study of GV20-0251 in Advanced or Refractory Solid Tumors | recruiting | Phase 1 | 10 | West China HospitalOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05743621 | Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer | recruiting | Phase 1 | 30 | Weill Medical College of Cornell UniversityOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT07242014 | 68Ga-XACP3 PET/CT in Prostate Cancer | recruiting | N/A | 60 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT03408964 | Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients | recruiting | — | 600 | Oncology Institute of Southern SwitzerlandOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT04543799 | Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer(SIESTA) | recruiting | — | 60 | Oncology Institute of Southern SwitzerlandOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT05850182 | Lifestyle Intervention in Patients With Metastatic Prostate Cancer(ACTIDIET-PRO) | recruiting | N/A | 30 | Oncology Institute of Southern SwitzerlandOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06917781 | Prostate Cancer Burden and Heterogeneity Evaluation Towards Liquid Biopsy: a Correlation Study to 18FDCFPyL PET and Patients Outcome(TAYLOR) | recruiting | N/A | 80 | Institut Claudius RegaudOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07131956 | Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy | recruiting | — | 200 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07163910 | Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study | recruiting | Phase 2 | 93 | baotai LiangOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06046131 | Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.(KP-CARAIBES) | recruiting | N/A | 3,000 | Centre Hospitalier Universitaire de la GuadeloupeOTHER | 2 | Nov 17, 2025 | clinicaltrials |
| NCT07231159 | Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots | recruiting | — | 200 | AdventHealthOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT04115254 | Stereotactic Magnetic Resonance Guided Radiation Therapy | recruiting | N/A | 397 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 13, 2025 | clinicaltrials |
| NCT06398639 | Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer(PRS) | recruiting | N/A | 1,500 | Adam S. Kibel, MDOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT04550845 | Understanding of Genetics by Men at Risk for Prostate Cancer | recruiting | N/A | 90 | Mayo ClinicOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT07071207 | Effect of Text Message Reminders on M-ISI Score After Prostate Surgery(TextMsgM-ISI) | recruiting | N/A | 132 | University of RochesterOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT06062745 | Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT | recruiting | Phase 1 | 30 | Brigham and Women's HospitalOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT06659614 | Prostate Tissue BioBank(PTBB) | recruiting | — | 200 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT07219303 | Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer(DE-CART) | recruiting | N/A | 80 | Fox Chase Cancer CenterOTHER | 1 | Oct 29, 2025 | clinicaltrials |
| NCT07222436 | Circulating Tumor DNA in High Risk Localized Prostate Cancer | recruiting | — | 24 | University of PittsburghOTHER | 1 | Oct 29, 2025 | clinicaltrials |
| NCT03452774 | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | recruiting | — | 50,000 | Massive Bio, Inc.INDUSTRY | 2 | Oct 28, 2025 | clinicaltrials |
| NCT05919329 | Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy | recruiting | Phase 4 | 80 | OHSU Knight Cancer InstituteOTHER | 1 | Oct 24, 2025 | clinicaltrials |
| NCT06165302 | Exercise in Prostate Cancer | recruiting | N/A | 20 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 20, 2025 | clinicaltrials |
| NCT06141993 | ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials(ARCTIC) | recruiting | — | 120 | Duke UniversityOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT06960291 | Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada(EXCEL) | recruiting | N/A | 740 | University of CalgaryOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT07141121 | Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen(IMARHGIN) | recruiting | N/A | 78 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT07209878 | 68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI | recruiting | Phase 2 / Phase 3 | 100 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT05869682 | Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy | recruiting | Phase 2 | 210 | City of Hope Medical CenterOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT06433349 | A Multi-center Investigation of Family Health. | recruiting | — | 240 | Odense University HospitalOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT05603559 | 177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer | recruiting | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Oct 3, 2025 | clinicaltrials |
| NCT06517901 | Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer(FOCUS-PC) | recruiting | N/A | 1,306 | Albany Medical CollegeOTHER | 2 | Oct 3, 2025 | clinicaltrials |
| NCT05346848 | Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer(DARIUS) | recruiting | Phase 2 | 62 | Institut BergoniéOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT06824818 | Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients | recruiting | N/A | 155 | University of ChicagoOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT02705846 | Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations(GENPROS) | recruiting | — | 4,260 | Institute of Cancer Research, United KingdomOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT06817668 | Evaluating Tolerability of ePUHRT With Brachytherapy Boost | recruiting | N/A | 31 | Indiana UniversityOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT07055165 | Connect2Care: Prostate Cancer Education and Screenings for African American Men | recruiting | N/A | 466 | University of OklahomaOTHER | 1 | Sep 25, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Dec 5, 2025source: clinicaltrials